Abstract
Allergic rhinitis is a disease of the nasal mucosa, which is based on allergic inflammation caused by the action of different natureallergens. Allergic rhinitis is quite common among the population, often occurs with frequent complications, resulting in decreased performance and quality of patients’life. Late or not effective therapy for this disease can lead to chronic disease and a combination of other pathologies, such as sinusitis, asthma and others.Primarily due to allergic inflammation in the lining of the nasal cavity,the allergen may persist for several weeks after exposure. Inflammation in the nasal cavitylining, triggered by allergens, leads to the accumulation of eosinophils, dendritic cells, T-lymphocytes and epithelial cells, which in its turn leads to activation and increased production of adhesion molecules by endothelial cells.Therapeutic help with allergic rhinitis may have the following areas:a) mechanical evacuation allergens;b) the use of pharmacological agents aimed at suppression of allergic process;c) the use of allergen-specific therapy;d) rational combination of the above directions for proper effect.Aim. Hold technological characteristics of salt dosage forms which are used as evacuation agents in the treatment of allergic rhinitis.Materials and methods. The material is known formulation, namely nasal saline solution. Information was taken from thesis, articles, patents and dissertation, etc.Results and discussion.Evacuation direction of curative care in allergic rhinitis caused by necessity of mechanical removal of allergens from the nasal cavity mucous areas. To do this, salt solutions of different compositionare used. According to the UkrainianState Register of medicines,salineis most common medicine in the domestic market amongpharmacotherapeutic group "means used for diseases of the nose". Range of nasal dosage forms is dominated by imported drugs, the share of domestic drugs is only 31.25%. As active ingredients, saline manufacturers mostly use sodium chloride, seawater and complex trace elements (magnesium, sodium, calcium) in different ratios. Such intranasal solutions by nature are mostly hypo or isotonic drugs. An exception is Aqua Maris® Strong (producer of "Jadran" Galenic Laboratory, Croatia), which is hypertonic solution of sterile seawater. As the solvent purified water or water for injectionare used. To ensure the stability of nasal dosage forms, some manufacturers of the tracks added preservatives, derivatives of quaternary ammonium compounds (benzalkonium chloride) and aromatic alcohols (benzyl alcohol). To normalize the pH substances of different chemical nature, such as sodium hydrogen phosphate dihydrate, sodium dihydrogen phosphate dihydrate, hydrochloric acidare used.Despite the existing range of drugs aimed at treatment and prevention of allergic rhinitis in patients,there is currentlyno safe and effectivetool that can fully provide therapeutic effect. When developing new means for intranasal pharmacotherapy of allergic rhinitis it is rational touse minerals of national origin, which will not only provide evacuation allergens, but also due to its high quality components will implement anti-inflammatory activity.Conclusions. As a result of research it was conducted that among intranasal medicines the natural salt is used for the treatment and prevention of allergic rhinitis. It is established that complex magnesium minerals from raw materials of natural originare perspective to be used.
Highlights
З метою надання технологічної характеристики сольових лікарських форм, що застосовуються як евакуаційні агенти при терапії алергічних ринітів, на основі відомостей фахової літератури вивчили склади відомих назальних сольових розчинів
The creation of new intranasal drug based on raw materials of natural origin for allergic rhinitis combined therapy B
The article is devoted to the choice of active substances and excipients in creation of new intranasal drug for adjuvant therapy of allergic rhinitis
Summary
Ключові слова: інтраназальні лікарські форми, алергічний риніт, природна сировина. Для розширення асортименту вітчизняних інтраназальних препаратів перспективно використовувати комплекс магнієвмісних мінералів на основі сировини природного походження. Перспективы создания нового интраназального лекарственного средства на базе сырья природного происхождения для комплексной терапии аллергического ринита Б. С целью технологической характеристики солевых лекарственных форм, которые используются как эвакуационные агенты при терапии аллергических ринитов, на основе специализированной литературы изучили составы известных назальных солевых растворов. Для расширения ассортимента отечественных интраназальных препаратов перспективно использовать комплекс магнийсодержащих минералов на основе сырья природного происхождения. Ключевые слова: интраназальные лекарственные формы, аллергический ринит, природное сырье. The creation of new intranasal drug based on raw materials of natural origin for allergic rhinitis combined therapy B. Aim. The article is devoted to the choice of active substances and excipients in creation of new intranasal drug for adjuvant therapy of allergic rhinitis
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Current issues in pharmacy and medicine: science and practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.